More than three years after the global COVID-19 health emergency ended, the virus continues to cause hospitalisations and ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

In an exploratory analysis of 20 participants switching from ocrelizumab, BRIUMVI treatment was associated with increased regulatory T cells and decreased inflammatory monocytes at Week 12, suggesting ...

The US FDA has approved GSK’s Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today new Phase III data for investigational fenebrutinib in multiple sclerosis (MS), demonstrating reduced markers of ...

Animals Around The Globe is a travel platform focused on wildlife and unique destinations, where you can discover all your ...